Mission, history and background
Mission, history and background
Oncopole is a center for research, development and investment to accelerate the fight against cancer.
The idea took shape during a discussion between members of the Quebec delegation at BIO 2015, including Dr. Gaétan Barrette (Minister of Health and Social Services), Mr. Rémi Quirion (Quebec’s Chief Scientist) and Merck executives and scientists, including the President and General Manager of Merck Canada Inc., Mr. Chirfi Guindo.
The aim was to build bridges between the various resources available to ensure a coherent and competitive system in Quebec. The project was born of a desire to demonstrate the remarkable spirit of collaboration that exists in Quebec.
A unique public-private partnership co-creation process. Merck will invest $15 million over three years to launch Oncopole, which will operate under the auspices of the Fonds de recherche du Québec – Santé (FRQS).
Mission
To act as a catalyst and harness the full potential of Quebec’s research and innovation ecosystem to accelerate the fight against cancer.
Mobilize the best research centers around a common vision focused on collaboration and resource sharing through a multidisciplinary approach.
Innovate by accelerating the commercialization of discoveries to develop cutting-edge clinical applications and support entrepreneurship training.
Healing by prioritizing high-impact projects and practices for patients.
Vision
Position Québec as a key player by developing a pole of excellence in oncology, based on strategic investments and partnerships supporting innovation for the benefit of patients.
An ongoing, co-creative process
Oncopole is a unique co-creation partnership whose implementation is inclusive and connected to the scientific community. The management committee led a series of consultations in the form of workshops with experts to draw up the strategic plan.
Oncopole would like to thank the following experts: